Trial Profile
A Phase 1, Open-Label Study to Evaluate the Safety and Pharmacokinetics of Local Administration of EXPAREL When Administered for Prolonged Postsurgical Analgesia in Subjects Undergoing Open Spinal Fusion or Reconstructive Surgery
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2017
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Pacira Pharmaceuticals
- 12 Oct 2017 Status changed from recruiting to completed.
- 28 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Jul 2017.
- 28 Apr 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Jul 2017.